Advanced search×

[The duration of psychosomatic rehabilitation: provisions, influencing factors, recommendations].

M M Nosper

Rehabilitation (Stuttg) 47(1):8-13 (2008) PMID 18247266

The decision of the German legislator to limit rehabilitation programme participation under the health-insurance scheme to a duration of three weeks had been oriented less by rehabilitation-scientific findings rather than by economic considerations. This is the background for discussing the question to what extent medical experience and empirical data are providing new information as to the durations of rehabilitation necessary and feasible in the field of psychosomatic rehabilitation and as to measures capable of supporting its effectiveness without extending the duration of therapy.

DOI: 10.1055/s-2007-1004605
Version: za2963e q8za0 q8zbe q8zcf q8zd5 q8ze4 q8zf2 q8zg7

Similar articles you may find interesting…

  1. Cyclin-dependent kinase inhibitor therapy for hematologic malignancies.
    Prithviraj Bose, Gary L Simmons, and Steven Grant

    Expert Opin Investig Drugs (2013) PMID 23647051

    Cyclin-dependent kinases (CDKs) regulate cell cycle progression. Certain CDKs (e.g., CDK7, CDK9) also control cellular transcription. Consequently, CDKs represent attractive targets for anticancer drug development, as their aberrant expression is common in diverse malignancies, and CDK inhibition ca...
  2. Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins.
    Qiuna Zhou, Xiaohui Wei, and Zhengtao Wang

    Carbohydr Polym 95(2):733-9 (2013) PMID 23648035

    This study investigates the solubility of baicalein (Ba) with the addition of modified cyclodextrins using phase solubility method. The solubility of Ba in the presence of natural (α-, β-, and γ-) cyclodextrins and its derivatives, namely, hydroxypropyl-β-cyclodextrin (HP-β-CD)...
  3. The study design and rationale of the randomized controlled trial: translating COPD guidelines into primary care practice.
    Donna R Parker, Charles B Eaton, and Joseph Wroblewski

    BMC Fam Pract 14(1):56 (2013) PMID 23641803

    We will also examine the use of a patient activation tool - 'MyLungAge' - to prompt patients at risk for or who have COPD to request spirometry confirmation and to request support for smoking cessation if a smoker. DISCUSSION: Using a multi-modal intervention of patient activation and a technology-s...
    PDF not found